(Q42282037)

English

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation

scientific article published on 20 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

author name string

Ding-Bao Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Qiu-Jing Song

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yun-Xin Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yu-Hong Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dan-Hua Shen

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

117-124

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1244-1

21 January 2018

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The efficacy and safety of donor lymphocyte infusion to treat Epstein-Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinicopathologic study of post-transplant lymphoproliferative disorders]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23255160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-012-1244-1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42282037&oldid=2205205615"